Erratum: Corrigendum to (Cancer Letters (2013) 340(1) (82–87) (S0304383513005089) (10.1016/j.canlet.2013.07.003));Telomerase activation as a repair response to radiation-induced DNA damage in Y79 retinoblastoma cells

Cancer Letters

Volumn 340, Issue 1, 2013, Pages 82-87

  Akiyama, Masaharu ^a   Ozaki, Kohji ^a   Kawano, Takeshi ^a   Yamada, Osamu ^b   Kawauchi, Kiyotaka ^c   Ida, Hiroyuki ^a   Yamada, Hisashi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

DNA damage response; Human telomerase reverse transcriptase; Ionizing radiation; Retinoblastoma; Telomerase

Indexed keywords

HISTONE H2AX; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2; PROTEIN KINASE B; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR RELA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEPHOSPHORYLATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IONIZING RADIATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RETINOBLASTOMA;

EID: 84883762969     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.07.032     Document Type: Erratum

References (35)

1. Suzuki S., Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int. J. Clin. Oncol. 2004, 9:1-6.
2. Yanagisawa T. Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma. Int. J. Clin. Oncol. 2004, 9:13-24.
3. Moll A.C., Imhof S.M., Bouter L.M., Tan K.E.W.P. Second primary tumors in patients with retinoblastoma. Ophthalmic Genet. 1997, 18:27-34.
4. Woo K.I., Harbour J.W. Review of 676 second primary tumors in patients with retinoblastoma: association between age at onset and tumor type. Arch. Ophthalmol. 2010, 128:865-870.
5. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Gene Dev. 2005, 19:2100-2110.
6. Ayouaz A., Raynaud C., Heride C., Revaud D., Sabatier L. Telomeres: hallmarks of radiosensitivity. Biochemie 2008, 90:60-72.
7. Denchi E.L. Give me a break: how telomeres suppress the DNA damage response. DNA Repair 2009, 8:1118-1126.
8. Natarajan M., Mohan S., Konopinski R., Otto R.A., Herman T.S. Induced telomerase activity in primary aortic endothelial cells by low-LET-radiation is mediated through NF-κB activation. Br. J. Radiol. 2008, 81:711-720.
9. Neuhof D., Zwicker F., Kuepper J.H., Debus J., Weber K.J. Activation of telomerase by ionizing radiation: differential response to the inhibition of DNA double-strand break repair by abrogation of poly(ADP-ribosyl)ation, by LY294002, or wortmannin. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:887-894.
10. Ram R., Uziel O., Eldan O., Fenig E., Beery E., Lichtenberg S., Nordenberg Y., Lahav M. Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via Ras/Phosphatidylinositol 3-kinase/Akt pathway. Clin. Cancer Res. 2009, 15:914-923.
11. Terao Y.M., Akiyama M., Yuza Y., Yanagisawa T., Yamada O., Kawano T., Agawa M., Ida H., Yamada H. Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines. Exp. Eye Res. 2009, 89:200-208.
12. Leteurtre F., Li X., Gluckman E., Carosella E.D. Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia 1997, 11:1681-1689.
13. Yan Y., Cao P.T., Greer P.M., Nagengast E.S., Kolb R.H., Mumby M.C., Cowan K.H. Protein phosphatase 2A has an essential role in the activation of γ-irradiation-induced G2/M checkpoint response. Oncogene 2010, 29:4317-4329.
14. Mao Z., Bozzella M., Seluanov A., Gorbunova V. DNA repair by nonhomologus end joining and homologous recombination during cell cycle in human cells. Cell Cycle 2008, 7:2902-2906.
15. Tomlinson R.L., Ziegler T.D., Supakorndej T., Terns R.M., Terns M.P. Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 2006, 17:955-965.
16. Lobrich M., Jeggo P.A. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat. Rev. Cancer 2007, 7:861-869.
17. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. P53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser46-phosphorylated p53. Cell 2000, 102:849-862.
18. Yoshida K., Liu H., Miki Y. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J. Biol. Chem. 2006, 281:5734-5740.
19. Dent P., Yacoub A., Fisher P.B., Hagan M.P., Grant S. MAPK pathways in radiation responses. Oncogene 2003, 22:5885-5896.
20. Masutomi K., Possemato R., Wong J.M.Y., Currier J.L., Tothova Z., Manola J.B., Ganesan S., Lansdorp P.M., Collins K., Hahn W.C. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. USA 2005, 102:8222-8227.
21. Tamakawa R.A., Fleisig H.B., Wong J.M.Y. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell-cycle-specific manner. Cancer Res. 2010, 70:8684-8694.
22. Lamy E., Goetz V., Erlacher M., Herz C., Mersch-Sundermann V. HTERT: another brick in the wall of cancer cells. Mutat. Res. 2013, 752:119-128.
23. Akiyama M., Hideshima T., Hayashi T., Tai Y.T., Mitsiades C.S., Mitsiades N., Chauhan D., Richardson P., Munshi N.C., Anderson K.C. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res. 2002, 62:3876-3882.
24. Akiyama M., Hideshima T., Hayashi T., Tai Y.T., Mitsiades C.S., Mitsiades N., Chauhan D., Richardson P., Munshi N.C., Anderson K.C. Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res. 2003, 63:18-21.
25. Akiyama M., Yamada O., Hideshima T., Yanagisawa T., Yokoi K., Fujisawa K., Eto Y., Yamada H., Anderson K.C. TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytes. Biochem. Biophys. Res. Commun. 2004, 316:528-532.
26. Wu Z.H., Shi Y., Tibbetts R.S., Miyamoto S. Molecular linkage between the kinase ATM and NF-κB signaling in response to genotoxic stimuli. Science 2006, 311:1141-1146.
27. Aravindan N., Veeraraghavan J., Madhusoodhanan R., Herman T.S., Natarajan M. Curcumin regulates low-linear energy transfer γ-radiation-induced NF-κB-dependent telomerase activity in human neuroblastoma cells. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79:1206-1215.
28. Xu D., Wang Q., Gruber A., Bjorkholm M., Chen Z., Zaid A., Selivanova G., Peterson C., Wiman K.G., Pisa P. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 2000, 19:5123-5133.
29. Kang S.S., Kwon T., Kwon D.Y., Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 1999, 274:13085-13090.
30. Li H., Zhao L.L., Funder J.W., Liu J.P. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 1997, 272:16729-16732.
31. Haendeler J., Hoffmann J., Rahman S., Zeiher A.M., Dimmeler S. Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation. FEBS Lett. 2003, 536:180-186.
32. Chung J., Khadka P., Chung I.K. Nuclear import of hTERT requires a bipartite nuclear localization signal and Akt-mediated phosphorylation. J. Cell Sci. 2012, 125(2012):2684-2697.
33. Haendeler J., Drose S., Buchner N., Jakob S., Altschmied J., Goy C., Spyridopoulos I., Zeiher A.M., Brandt U., Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler. Thromb. Vasc. Biol. 2009, 29:929-935.
34. Abramson D.H., Frank C.M. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 1998, 105:573-579.
35. Cesare A.J., Kaul Z., Cohen S.B., Napier C.E., Pickett H.A., Neumann A.A., Reddel R.R. Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nat. Struct. Mol. Biol. 2009, 16:1244-1252.